← Back to All Stocks

NeuroSense Therapeutics Ltd. (NRSN) Analysis

Generated on: 2025-08-20 19:20:11 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 12,538,862 shares

Analysis Values

Current Price
$1.14
Predicted Price
$1.04
Expected Return
-7.41%
Confidence Score
0.84
RSI (14)
32.35
MACD
-0.19
Volume
572,004
Float Shares
12,538,862
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

NRSN

NeuroSense Therapeutics Ltd.
-7.41%
Price: $1.14
Confidence: 0.84
News
Low Float
Last updated: 2025-08-20 19:20:11

Technical Analysis

RSI: 32.35
MACD: -0.19
Technical Analysis Graph

Risk Analysis

Volatility
92.64%
Max Drawdown
-56.63%
Beta
1.0
Risk Score
79.7

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights
Benzinga - 2025-05-12 19:08
Last Wednesday, NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) said it scaled up its production of PrimeC to a commercial scale. PrimeC, NeuroSense’s lead drug candidate, is a novel extended-release oral formulation with a unique fixed-dose combination of two FDA-approved drugs: ciprofloxacin and celecoxib for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease. NeuroSense said it bolstered its supply chain by implementing comprehensive Chemistry, Manufacturing, and Controls (CMC) enhan

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.